Middle East Retail Pharmacy Market By Type of Pharmacy (Chain Pharmacies, Independent Pharmacies, Hospital Pharmacies, Mail Order Pharmacies, Online Pharmacies); By Type of Prescription (Prescription Drugs [Rx], Over-the-Counter [OTC] Drugs); By Service Offered (Medication Dispensing, Health Screenings, Vaccination Services, Consultation and Counseling, Chronic Disease Management); By Product Type (Generic Drugs, Branded Drugs); By Application (Oncology, Diabetes, Neurology, Others); By Customer (Paediatric, Adults, Geriatric) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
Price: $3699
Published: | Report ID: 90441 | Report Format : Excel, PDF
The Middle East Retail Pharmacy Market is projected to grow from USD 44,172.86 million in 2024 to an estimated USD 52,982.57 million by 2032, with a compound annual growth rate (CAGR) of 2.30% from 2025 to 2032. This growth reflects the region’s expanding healthcare infrastructure and increasing demand for pharmaceutical services.
Key drivers of this market include rising healthcare expenditures, an aging population, and a growing prevalence of chronic diseases. Additionally, the shift towards over-the-counter (OTC) medications and the expansion of e-pharmacy services are enhancing accessibility and convenience for consumers. Technological advancements, such as pharmacy automation and digital health platforms, are further contributing to market growth by improving operational efficiency and patient care.
Geographically, the United Arab Emirates (UAE) and Saudi Arabia are leading the market, driven by robust healthcare policies and significant investments in medical infrastructure. Key players in the Middle East retail pharmacy sector include Nahdi Medical Company, Al-Dawaa Medical Services Co., and BinSina Pharmacy, which are expanding their presence through both physical stores and digital platforms to meet the evolving needs of the population.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research!
The Middle East retail pharmacy market is projected to grow from USD 44,172.86 million in 2024 to USD 52,982.57 million by 2032, with a CAGR of 2.30% from 2025 to 2032, driven by increasing healthcare demand.
The Global Retail Pharmacy Market is expected to grow from USD 14,45,920.00 million in 2024 to USD 19,65,958.05 million by 2032, at a CAGR of 3.92% from 2025 to 2032.
Key drivers include rising healthcare expenditures, an aging population, increasing chronic disease prevalence, and growing consumer preference for over-the-counter (OTC) medications and e-pharmacy services.
Innovations in pharmacy automation, digital health platforms, and e-pharmacy solutions are enhancing operational efficiency and accessibility, further stimulating market growth.
Regulatory complexities and price sensitivity among consumers are major challenges, as pharmacies must balance affordability with quality service offerings.
Saudi Arabia and the UAE lead the market, driven by robust healthcare policies, significant investments in medical infrastructure, and high consumer demand for pharmaceutical services.
Leading players such as Nahdi Medical Company, Al-Dawaa Medical Services Co., and BinSina Pharmacy are expanding their market share through both physical and online platforms.
The market will see continued growth through digital transformation, diversification of services, and an increasing focus on preventive healthcare and personalized services.
Report Scope
This report segments the Middle East Retail Pharmacy Market as follows:
Market Drivers
Increasing Prevalence of Chronic Diseases and an Aging Population
One of the primary drivers of the Middle East retail pharmacy market is the growing burden of chronic diseases such as diabetes, cardiovascular conditions, respiratory illnesses, and obesity. Countries in the region, particularly Saudi Arabia, the United Arab Emirates (UAE), and Qatar, report high incidences of lifestyle-related disorders due to sedentary behavior, unhealthy dietary habits, and rising stress levels. This epidemiological shift has significantly increased the demand for prescription medications, regular drug refills, and patient counseling services—core offerings of retail pharmacies. For instance, according to the International Diabetes Federation (IDF), the prevalence of diabetes in the UAE was 16.3% in 2021, one of the highest rates globally, necessitating consistent medication and monitoring. Simultaneously, the Middle East is witnessing a demographic shift characterized by an aging population. Older adults require more frequent medical attention, including medication for long-term disease management and age-related conditions such as arthritis, hypertension, and cognitive decline. For instance, Saudi Arabia’s Ministry of Health has implemented home healthcare programs that include pharmaceutical services for elderly patients, ensuring medication adherence and reducing hospital visits. This growing elderly population continues to drive footfall and prescription volumes at retail pharmacy chains. The combination of chronic disease management and geriatric care has amplified the importance of accessible, community-based pharmacies that offer not just medicines, but also pharmaceutical guidance, wellness products, and diagnostic support. As a result, retail pharmacies have evolved into essential healthcare access points, playing a central role in public health maintenance across the region.
Expanding Healthcare Infrastructure and Government Initiatives
Governments across the Middle East have prioritized healthcare development as part of national transformation strategies. Initiatives such as Saudi Arabia’s Vision 2030, the UAE’s National Health Strategy, and Qatar’s National Health Vision are designed to diversify economies and build robust, sustainable healthcare ecosystems. These programs emphasize improving healthcare access, digital integration, preventive care, and private sector participation—all of which significantly benefit retail pharmacies. For instance, Saudi Arabia’s Vision 2030 includes the establishment of over 100 new healthcare facilities, many of which integrate retail pharmacy services to enhance accessibility. Retail pharmacies are being integrated into these health policy frameworks to support chronic disease management, provide vaccination services, promote health literacy, and offer preventive care. For instance, the UAE’s Ministry of Health and Prevention launched the “Riayati” platform, a national e-health system that digitizes patient records and prescriptions, enabling pharmacies to streamline operations and ensure drug authenticity. Many regional governments have liberalized pharmacy ownership laws, encouraged foreign investment, and supported the licensing of large pharmacy chains, which has led to the proliferation of retail outlets across urban and semi-urban areas. These advancements, backed by supportive policies and investments, are enabling retail pharmacies to expand their footprint and enhance service delivery throughout the region.
Rise of Digital Pharmacies and Technology Integration
Digital transformation is reshaping the retail pharmacy landscape in the Middle East. The emergence of e-pharmacies and the integration of digital tools such as mobile apps, e-prescriptions, telepharmacy services, and AI-powered health management platforms have significantly improved patient convenience and operational scalability. Consumers in urban centers increasingly prefer digital channels for medicine ordering, refills, and wellness consultations, especially in the post-pandemic era where remote access to healthcare services has become a norm. Technology has enabled retail pharmacies to extend their services beyond the physical store, offering doorstep delivery, automatic prescription reminders, and access to product information in multiple languages. Some pharmacy chains have adopted automated dispensing systems, CRM tools, and data analytics platforms to optimize inventory, personalize services, and enhance customer engagement. These advancements have contributed to greater consumer trust and loyalty. The growing acceptance of digital pharmacy platforms is not only streamlining the medication procurement process but also fostering a new business model where convenience, reliability, and digital literacy drive long-term market growth.
Growing Consumer Awareness and Shift Towards Preventive Healthcare
A significant transformation in consumer behavior is also contributing to the expansion of the Middle East retail pharmacy market. Rising health consciousness, fueled by higher educational levels, increased internet penetration, and the impact of public health campaigns, has led to a surge in demand for over-the-counter (OTC) drugs, health supplements, personal care products, and preventive health solutions. Consumers are increasingly taking charge of their health by seeking self-care options, exploring alternative therapies, and incorporating wellness products into their daily routines. Retail pharmacies are capitalizing on this trend by expanding their product portfolios to include vitamins, nutraceuticals, herbal remedies, fitness supplements, and home diagnostics. In-store pharmacists play a crucial advisory role, helping consumers choose appropriate OTC products and preventive care solutions. Additionally, pharmacies are incorporating wellness corners, immunization booths, and health screening services into their outlets to attract health-conscious customers. This consumer-driven shift is transforming retail pharmacies from mere dispensers of medicine into comprehensive health and wellness hubs. It is also fostering a more proactive and preventive approach to healthcare, reinforcing the market’s long-term sustainability and resilience.
Market Trends
Expansion of Omnichannel Retailing Models
Retail pharmacies in the Middle East are rapidly adopting omnichannel strategies to meet evolving consumer expectations for convenience, accessibility, and personalized service. For instance, during the pandemic, pharmacies in the UAE reported a 60% increase in online prescription orders, reflecting the growing reliance on digital platforms. Traditional brick-and-mortar pharmacies are increasingly integrating digital platforms—such as mobile apps, e-commerce websites, and WhatsApp-based ordering systems—to provide seamless customer experiences across physical and virtual touchpoints. Customers now expect flexible options such as online consultations, home delivery of medications, digital prescription uploads, and subscription-based medication plans. As a result, pharmacy chains are investing in advanced CRM systems, secure payment gateways, and inventory synchronization tools to enhance service quality and operational efficiency. By leveraging omnichannel models, pharmacies can offer real-time stock availability, personalized health alerts, and loyalty rewards programs. Moreover, this trend is aligning with the broader healthcare digitization initiatives led by governments in the UAE, Saudi Arabia, and Qatar, which are encouraging the adoption of health-tech solutions to improve care delivery, medication adherence, and public health outcomes.
Diversification of Pharmacy Services Beyond Medication Dispensing
Retail pharmacies in the Middle East are increasingly repositioning themselves as integrated health service providers, expanding their roles beyond traditional medication dispensing. For example, over 70% of pharmacies in Saudi Arabia now offer vaccination services, contributing to improved public health outcomes. This diversification includes the introduction of in-store clinical services such as vaccination programs, basic health screenings (blood pressure, glucose levels, cholesterol), wellness counseling, smoking cessation support, and medication therapy management. Pharmacists are receiving expanded training, 85% of pharmacists in the region are now certified to provide chronic disease management consultations. Furthermore, pharmacies are increasingly collaborating with insurance providers and public health authorities to offer reimbursable clinical services, thereby increasing customer engagement and financial viability. By expanding their service portfolio, pharmacies are enhancing patient outcomes, reducing the burden on hospitals, and improving the overall efficiency of the healthcare ecosystem. This trend is likely to accelerate as regional governments continue to push for universal health coverage and integrated care delivery systems under national transformation strategies.
Rapid Growth of E-Pharmacy and Telepharmacy Platforms
The Middle East is witnessing a significant surge in e-pharmacy and telepharmacy adoption, transforming the way consumers access pharmaceutical products and healthcare services. The rise of e-commerce giants, local health-tech startups, and digital health platforms is fueling this trend, particularly in the UAE, Saudi Arabia, and Kuwait, where digital infrastructure and consumer readiness are strong. E-pharmacies allow patients to order prescription and over-the-counter medications online, with the added convenience of doorstep delivery, real-time stock tracking, and online pharmacist consultations. Telepharmacy, which involves remote consultation with licensed pharmacists through audio or video calls, has gained prominence during and after the COVID-19 pandemic. It is increasingly being used for medication counseling, dosage clarifications, and follow-up on treatment adherence. This digital approach improves access to pharmaceutical care, especially in underserved or remote areas where physical pharmacies may be scarce. Additionally, regulatory bodies across the region are formalizing guidelines for e-prescriptions and remote dispensing, creating a favorable legal framework for growth. The widespread use of mobile health applications, integration with electronic health records, and AI-enabled platforms is further supporting the expansion of virtual pharmacy services, helping providers deliver efficient, compliant, and patient-centric pharmaceutical care.
Rise in Health and Wellness Product Demand
A growing focus on health and wellness is reshaping the product landscape of retail pharmacies in the Middle East. Consumers are increasingly prioritizing preventive health and lifestyle management, leading to a surge in demand for vitamins, dietary supplements, nutraceuticals, herbal remedies, fitness-related products, and personal care items. This shift is driven by rising awareness of self-care, social media influence, and government-led health promotion campaigns encouraging disease prevention and healthy living. Pharmacies are responding by expanding their non-prescription portfolios, dedicating more shelf space to wellness products, and collaborating with global brands to introduce premium health offerings. Some chains are also launching private-label health supplements and wellness goods to cater to value-conscious segments while maintaining quality. In-store pharmacists are playing a consultative role by recommending suitable wellness regimens and guiding consumers on supplement usage, which enhances customer trust and loyalty.
Market Challenges
Regulatory Variations and Compliance Complexities
The Middle East retail pharmacy market faces significant challenges stemming from regulatory variations across different countries and regions. Each country, whether Saudi Arabia, the UAE, Qatar, or Kuwait, enforces its own pharmacy laws, licensing requirements, drug pricing regulations, and operational guidelines. Navigating these diverse regulatory landscapes often requires localized strategies and significant administrative efforts, posing a barrier to regional expansion for both local and multinational pharmacy chains. Moreover, evolving regulations related to pharmaceutical e-commerce, telepharmacy, data privacy, and cross-border transactions add additional layers of complexity. For instance, Saudi Arabia mandates the use of the Drug Track and Trace System (RSD), which requires pharmacies to verify the authenticity of pharmaceutical products through a barcode system, ensuring compliance with anti-counterfeiting measures. Pharmacy operators must continuously monitor regulatory updates, ensure compliance with drug authenticity verification systems, and adhere to government-mandated pricing controls, which sometimes compress profit margins. Regulatory unpredictability, especially concerning the approval of new services such as remote consultations and e-prescriptions, can delay service innovation and restrict operational flexibility. Non-compliance risks substantial penalties, reputation damage, and possible license revocation. Therefore, maintaining regulatory agility and investing in compliance systems becomes essential but resource-intensive for players operating in this market.
Intense Competition and Price Sensitivity
The growing number of retail pharmacy outlets, coupled with the entry of new digital and traditional players, has intensified competition across the Middle East market. Chains, independent pharmacies, and online platforms all vie for consumer attention, leading to aggressive pricing strategies, frequent promotional campaigns, and loyalty programs aimed at customer retention. While these tactics attract short-term business, they significantly erode profit margins and increase operational pressures on pharmacies, particularly smaller and independent operators. Additionally, many consumers exhibit high price sensitivity, especially for over-the-counter products, generics, and wellness goods, compelling pharmacies to offer competitive pricing or value-added services to differentiate themselves. The emergence of large e-commerce platforms offering pharmaceutical products at discounted rates further exacerbates the pricing pressure on brick-and-mortar outlets. Sustaining profitability while maintaining service quality, ensuring regulatory compliance, and investing in technology becomes a daunting balancing act. Long-term success will require pharmacy operators to innovate beyond pricing—through personalized services, advanced customer engagement, and operational efficiency improvements.
Market Opportunities
Expansion of Personalized Healthcare and Preventive Services
The Middle East retail pharmacy market holds substantial opportunity in the growing demand for personalized healthcare and preventive services. With rising consumer awareness regarding chronic disease management, wellness optimization, and preventive care, pharmacies are ideally positioned to offer tailored solutions beyond standard medication dispensing. Services such as medication therapy management, chronic disease monitoring, immunizations, diagnostic screenings, and personalized wellness consultations present untapped growth avenues. Pharmacies that integrate technology-enabled tools like electronic health records, AI-driven health assessments, and wearable health device integrations can enhance patient engagement and loyalty. This shift toward patient-centered care models aligns with national health strategies across the region, making pharmacies crucial players in delivering accessible and continuous healthcare. By positioning themselves as essential community healthcare partners, retail pharmacies can capture a larger share of healthcare spending and significantly enhance their revenue streams.
Strategic Growth through Digital Transformation and E-Pharmacy Expansion
Digitalization presents a transformative opportunity for retail pharmacy chains across the Middle East. The widespread adoption of smartphones, increasing internet penetration, and consumer preference for contactless healthcare services create a favorable environment for e-pharmacy and telepharmacy growth. Retailers that invest in robust digital platforms offering online consultations, e-prescription management, and home delivery services stand to gain substantial market share. Moreover, digital loyalty programs, AI-driven customer personalization, and mobile health management applications can enhance customer experiences and boost long-term engagement. Governments across the region are actively supporting healthcare digitalization, further reinforcing this opportunity. Pharmacies that strategically combine physical presence with strong online capabilities will position themselves as market leaders, tapping into both urban and remote customer bases and future-proofing their operations against shifting consumer behaviors.
Market Segmentation Analysis
By Type of Pharmacy
The Middle East retail pharmacy market is segmented based on the type of pharmacy into chain pharmacies, independent pharmacies, hospital pharmacies, mail-order pharmacies, and online pharmacies. Chain pharmacies dominate the market, driven by their extensive networks, brand recognition, and ability to offer standardized services across multiple locations. Independent pharmacies, while facing competition from large chains, continue to thrive in smaller communities by offering personalized services. Hospital pharmacies support inpatient and outpatient needs but are increasingly expanding into outpatient retail models to capture a broader patient base. Mail-order pharmacies are gaining traction as consumers seek convenience and cost savings, particularly for chronic medication refills. Online pharmacies are emerging rapidly, propelled by digitalization, favorable regulations, and the region’s high smartphone penetration, offering consumers accessibility and fast delivery services.
By Type of Prescription
Based on prescription type, the market is divided into prescription drugs (Rx) and over-the-counter (OTC) drugs. Prescription drugs account for the larger share due to the growing burden of chronic and complex diseases requiring physician-directed therapies. However, OTC drugs are witnessing strong growth, fueled by increased consumer inclination towards self-medication, preventive healthcare, and wellness products.
Segments
Based on Type of Pharmacy
Chain Pharmacies
Independent Pharmacies
Hospital Pharmacies
Mail Order Pharmacies
Online Pharmacies
Based on Type of prescription
Prescription Drugs (Rx)
Over-the-Counter (OTC) Drugs
Based on Service offered
Medication Dispensing
Health Screenings
Vaccination Services
Consultation and Counseling
Chronic Disease Management
Based on Product Type
Generic Drugs
Branded Drugs
Based on Application
Oncology
Diabetes
Neurology
Others
Based on Customer
Paediatric
Adults
Geriatric
Based on Region
UAE
Qatar
Kuwait
others
Regional Analysis
Saudi Arabia (36%)
Saudi Arabia commands the largest share of the Middle East retail pharmacy market, accounting for approximately 36% of total sales in the Middle East and Africa (MEA) region as of Q1 2024. The market’s growth is propelled by substantial government investment in healthcare infrastructure, a rising prevalence of chronic diseases, and a strong push towards digital health initiatives under the Vision 2030 framework. The retail pharmacy sector benefits from a robust hospital channel, which contributes nearly half of the pharmaceutical sales, and a growing number of chain pharmacies expanding their footprint across the kingdom.
United Arab Emirates (13%)
The United Arab Emirates (UAE) holds the second-largest market share, representing about 13% of the MEA pharmaceutical market. The UAE’s retail pharmacy market is characterized by rapid growth, with a 16.5% year-over-year increase reported in Q1 2024. This expansion is driven by a high demand for over-the-counter (OTC) medications, wellness products, and innovative pharmaceutical offerings. The country’s advanced logistics infrastructure and supportive regulatory environment have facilitated the proliferation of both brick-and-mortar and online pharmacies, catering to a health-conscious and tech-savvy population.
Key players
Al-Dawaa Pharmacies
Boots Pharmacy
Aster Pharmacy
United Pharmacies
Al Harbi Pharmacy
Competitive Analysis
The Middle East retail pharmacy market is characterized by the presence of established players who leverage extensive store networks, strong brand equity, and diversified service offerings. Al-Dawaa Pharmacies leads the competitive landscape with a wide range of pharmaceutical products, healthcare services, and aggressive expansion strategies across Saudi Arabia. Boots Pharmacy maintains a strong regional presence through its premium product assortment and innovative customer engagement initiatives. Aster Pharmacy capitalizes on its integrated healthcare network, offering seamless pharmacy and clinical services, especially in the UAE. United Pharmacies strengthens its market position by focusing on personalized service delivery and strategic store locations. Al Harbi Pharmacy continues to build its reputation through a community-centric approach and investment in digital transformation. Intense competition among these players drives continuous innovation, service diversification, and digital adoption, ensuring sustained market evolution. Players are increasingly focusing on enhancing omnichannel experiences, forging partnerships, and expanding wellness service portfolios to gain a competitive edge.
Recent Developments
As of March 31, 2024, Apollo Pharmacy operated 6,030 stores across approximately 1,200 cities and towns in 22 states and 5 union territories. The company continues to expand its digital healthcare platform, offering services like online medicine delivery and virtual doctor consultations.
In October 2024, Caring Pharmacy Retail Management Sdn Bhd, a 75%-owned unit of 7-Eleven Malaysia Holdings Bhd, announced acquisitions of equity interest and business assets in several pharmaceutical outlets for a combined cash consideration of RM48.86 million.
In June 2024, the Australian Competition and Consumer Commission (ACCC) expressed concerns that the proposed acquisition of Chemist Warehouse by Sigma Healthcare could substantially lessen competition in pharmacy retailing, potentially leading to higher prices and reduced service quality.
In January 2025, Watsons Philippines ended 2024 with 1,166 stores, expanding its community pharmacy format. The company opened more than 50 stores outside of Metro Manila.
Market Concentration and Characteristics
The Middle East retail pharmacy market exhibits moderate to high market concentration, dominated by a few major players such as Al-Dawaa Pharmacies, Boots Pharmacy, and Aster Pharmacy, alongside a large number of independent and regional pharmacies. The market is characterized by rapid consolidation, with leading chains expanding through acquisitions, franchise models, and digital platforms to strengthen their presence. High urbanization rates, a tech-savvy population, and increasing healthcare demands are shaping the market’s competitive dynamics. Additionally, the sector is defined by a growing focus on personalized healthcare services, preventive care offerings, and omnichannel retail models that combine physical stores with e-commerce capabilities. Regulatory support for digital health initiatives and investments in pharmacy automation further enhance market efficiency and service quality. However, intense competition, price sensitivity, and varying regulatory frameworks across countries create operational challenges, pushing players to innovate continuously and diversify their service portfolios to sustain growth and customer loyalty.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
The research report offers an in-depth analysis based on Type of Pharmacy, Type of prescription, Service offered, Product Type, Application, Customer and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
The Middle East retail pharmacy market will continue to expand steadily, driven by increasing healthcare expenditures and chronic disease prevalence across the region. Pharmacies will strengthen their role as essential healthcare providers, offering both therapeutic and preventive services to a growing patient base.
Digital transformation will reshape the pharmacy landscape, with e-pharmacy platforms, telepharmacy consultations, and mobile health applications becoming mainstream channels. Retailers will invest heavily in digital infrastructure to provide seamless online ordering, remote medication management, and virtual wellness consultations.
Omnichannel strategies will dominate growth initiatives, blending physical stores with digital platforms to deliver an integrated and customer-centric experience. Chain pharmacies will leverage CRM tools, loyalty programs, and real-time inventory tracking to boost customer retention and operational efficiency.
Preventive healthcare services such as vaccination clinics, health screenings, and wellness counseling will gain prominence within retail pharmacy operations. Pharmacies will reposition themselves as accessible centers for preventive care, aligning with regional health authority goals to improve public health.
The market will experience heightened consolidation, with larger chains acquiring smaller independent pharmacies to expand geographic reach and economies of scale. This trend will foster greater brand standardization, service uniformity, and stronger bargaining power with pharmaceutical suppliers and insurers.
Personalized medicine and targeted healthcare solutions will become key differentiators, supported by advancements in data analytics and patient profiling. Pharmacies will offer customized medication plans, nutritional counseling, and disease management programs tailored to individual health profiles.
Expansion into underserved and rural areas will become a strategic focus, supported by government initiatives to enhance healthcare accessibility. Pharmacy chains will explore innovative models such as mobile pharmacies and partnership-based expansions to capture new market segments.
Regulatory reforms will continue to support pharmacy sector modernization, promoting transparency, pricing control, and integration with national health systems. Compliance with evolving e-prescription frameworks and patient data protection standards will be crucial for sustainable business operations.
Consumer demand for health and wellness products, including nutraceuticals, fitness supplements, and herbal remedies, will drive non-prescription product sales. Pharmacies will broaden their product offerings and develop private-label brands to meet shifting consumer preferences towards preventive health.
Investment in pharmacist training and professional development will increase, aiming to enhance service quality, clinical expertise, and patient trust. Pharmacies will empower their workforce to deliver value-added services, bridging gaps in primary care delivery and strengthening long-term customer loyalty.
CHAPTER NO. 1 : INTRODUCTION 19
1.1.1. Report Description 19 Purpose of the Report 19 USP & Key Offerings 19
1.1.2. Key Benefits for Stakeholders 19
1.1.3. Target Audience 20
1.1.4. Report Scope 20 CHAPTER NO. 2 : EXECUTIVE SUMMARY 21
2.1. Middle East Retail Pharmacy Market Snapshot 21
2.1.1. Middle East Retail Pharmacy Market, 2018 – 2032 (USD Million) 22 CHAPTER NO. 3 : MIDDLE EAST RETAIL PHARMACY MARKET – INDUSTRY ANALYSIS 23
3.1. Introduction 23
3.2. Market Drivers 24
3.2.1. Growing Population 24
3.2.2. Increasing Health Awareness 25
3.3. Market Restraints 26
3.3.1. Stringent Regulatory Environment 26
3.4. Market Opportunities 27
3.4.1. Market Opportunity Analysis 27
3.5. Porter’s Five Forces Analysis 28 CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 29
4.1. Company Market Share Analysis – 2024 29
4.1.1. Middle East Retail Pharmacy Market: Company Market Share, by Volume, 2024 29
4.1.2. Middle East Retail Pharmacy Market: Company Market Share, by Revenue, 2024 30
4.1.3. Middle East Retail Pharmacy Market: Top 6 Company Market Share, by Revenue, 2024 30
4.1.4. Middle East Retail Pharmacy Market: Top 3 Company Market Share, by Revenue, 2024 31
4.2. Middle East Retail Pharmacy Market Company Revenue Market Share, 2024 32
4.3. Company Assessment Metrics, 2024 33
4.3.1. Stars 33
4.3.2. Emerging Leaders 33
4.3.3. Pervasive Players 33
4.3.4. Participants 33
4.4. Start-ups /SMEs Assessment Metrics, 2024 33
4.4.1. Progressive Companies 33
4.4.2. Responsive Companies 33
4.4.3. Dynamic Companies 33
4.4.4. Starting Blocks 33
4.5. Strategic Developments 34
4.5.1. Acquisitions & Mergers 34 New Product Launch 34 Regional Expansion 34
4.6. Key Players Product Matrix 35 CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 36
5.1. PESTEL 36
5.1.1. Political Factors 36
5.1.2. Economic Factors 36
5.1.3. Social Factors 36
5.1.4. Technological Factors 36
5.1.5. Environmental Factors 36
5.1.6. Legal Factors 36
5.2. Adjacent Market Analysis 36 CHAPTER NO. 6 : MIDDLE EAST RETAIL PHARMACY MARKET – BY TYPE OF PHARMACY SEGMENT ANALYSIS 37
6.1. Middle East Retail Pharmacy Market Overview, by Type of Pharmacy Segment 37
6.1.1. Middle East Retail Pharmacy Market Revenue Share, By Type of Pharmacy, 2023 & 2032 38
6.1.2. Middle East Retail Pharmacy Market Attractiveness Analysis, By Type of Pharmacy 39
6.1.3. Incremental Revenue Growth Opportunity, by Type of Pharmacy, 2024 – 2032 39
6.1.4. Middle East Retail Pharmacy Market Revenue, By Type of Pharmacy, 2018, 2023, 2027 & 2032 40
6.2. Chain Pharmacies 41
6.3. Independent Pharmacies 42
6.4. Hospital Pharmacies 43
6.5. Mail Order Pharmacies 44
6.6. Online Pharmacies 45 CHAPTER NO. 7 : MIDDLE EAST RETAIL PHARMACY MARKET – BY TYPE OF PRESCRIPTION SEGMENT ANALYSIS 46
7.1. Middle East Retail Pharmacy Market Overview, by Type of Prescription Segment 46
7.1.1. Middle East Retail Pharmacy Market Revenue Share, By Type of Prescription, 2023 & 2032 47
7.1.2. Middle East Retail Pharmacy Market Attractiveness Analysis, By Type of Prescription 48
7.1.3. Incremental Revenue Growth Opportunity, by Type of Prescription, 2024 – 2032 48
7.1.4. Middle East Retail Pharmacy Market Revenue, By Type of Prescription, 2018, 2023, 2027 & 2032 49
7.2. Prescription Drugs (Rx) 50
7.3. Over-the-Counter (OTC) Drugs 51 CHAPTER NO. 8 : MIDDLE EAST RETAIL PHARMACY MARKET – BY SERVICE OFFERED SEGMENT ANALYSIS 52
8.1. Middle East Retail Pharmacy Market Overview, by Service Offered Segment 52
8.1.1. Middle East Retail Pharmacy Market Revenue Share, By Service Offered, 2023 & 2032 53
8.1.2. Middle East Retail Pharmacy Market Attractiveness Analysis, By Service Offered 54
8.1.3. Incremental Revenue Growth Opportunity, by Service Offered, 2024 – 2032 54
8.1.4. Middle East Retail Pharmacy Market Revenue, By Service Offered, 2018, 2023, 2027 & 2032 55
8.2. Medication Dispensing 56
8.3. Health Screenings 57
8.4. Vaccination Services 58
8.5. Consultation and Counseling 59
8.6. Chronic Disease Management 60 CHAPTER NO. 9 : MIDDLE EAST RETAIL PHARMACY MARKET – BY PRODUCT TYPE SEGMENT ANALYSIS 61
9.1. Middle East Retail Pharmacy Market Overview, by Product Type Segment 61
9.1.1. Middle East Retail Pharmacy Market Revenue Share, By Product Type, 2023 & 2032 62
9.1.2. Middle East Retail Pharmacy Market Attractiveness Analysis, By Product Type 63
9.1.3. Incremental Revenue Growth Opportunity, by Product Type, 2024 – 2032 63
9.1.4. Middle East Retail Pharmacy Market Revenue, By Product Type, 2018, 2023, 2027 & 2032 64
9.2. Generic Drugs 65
9.3. Branded Drugs 66 CHAPTER NO. 10 : MIDDLE EAST RETAIL PHARMACY MARKET – BY APPLICATION SEGMENT ANALYSIS 67
10.1. Middle East Retail Pharmacy Market Overview, by Application Segment 67
10.1.1. Middle East Retail Pharmacy Market Revenue Share, By Application , 2023 & 2032 68
10.1.2. Middle East Retail Pharmacy Market Attractiveness Analysis, By Application 69
10.1.3. Incremental Revenue Growth Opportunity, by Application , 2024 – 2032 69
10.1.4. Middle East Retail Pharmacy Market Revenue, By Application , 2018, 2023, 2027 & 2032 70
10.2. Oncology 71
10.3. Diabetes 72
10.4. Neurology 73
10.5. Others 74 CHAPTER NO. 11 : MIDDLE EAST RETAIL PHARMACY MARKET – BY CUSTOMER SEGMENT ANALYSIS 75
11.1. Middle East Retail Pharmacy Market Overview, by Customer Segment 75
11.1.1. Middle East Retail Pharmacy Market Revenue Share, By Customer Segment, 2023 & 2032 76
11.1.2. Middle East Retail Pharmacy Market Attractiveness Analysis, By Customer Segment 77
11.1.3. Incremental Revenue Growth Opportunity, by Customer Segment, 2024 – 2032 77
11.1.4. Middle East Retail Pharmacy Market Revenue, By Customer Segment, 2018, 2023, 2027 & 2032 78
11.2. Paediatric 79
11.3. Adults 80
11.4. Geriatric 80 CHAPTER NO. 12 : RETAIL PHARMACY MARKET – MIDDLE EAST 81
12.1. Middle East 81
12.1.1. Key Highlights 81
12.1.2. Middle East Retail Pharmacy Market Revenue, By Country, 2018 – 2023 (USD Million) 82
12.1.3. Middle East Retail Pharmacy Market Revenue, By Type of Pharmacy, 2018 – 2032 (USD Million) 83
12.1.4. Middle East Retail Pharmacy Market Revenue, By Type of Prescription, 2018 – 2032 (USD Million) 84
12.1.5. Middle East Retail Pharmacy Market Revenue, By Service Offered, 2018 – 2032 (USD Million) 85
12.1.6. Middle East Retail Pharmacy Market Revenue, By Product Type, 2018 – 2032 (USD Million) 86
12.1.7. Middle East Retail Pharmacy Market Revenue, By Application, 2018 – 2032 (USD Million) 87
12.1.8. Middle East Retail Pharmacy Market Revenue, By Customer Segment, 2018 – 2032 (USD Million) 88
12.2. UAE 89
12.3. KSA 89
12.4. Israel 89
12.5. Turkey 89
12.6. Iran 89
12.7. Rest of Middle East 89 CHAPTER NO. 13 : COMPANY PROFILES 90
13.1. Al-Dawaa Pharmacies 90
13.1.1. Company Overview 90
13.1.2. Product Portfolio 90
13.1.3. Swot Analysis 90
13.1.4. Business Strategy 91
13.1.5. Financial Overview 91
13.2. Boots Pharmacy 92
13.3. Aster Pharmacy 92
13.4. United Pharmacies 92
13.5. Al Harbi Pharmacy 92
13.6. Company 6 92
13.7. Company 7 92
13.8. Company 8 92
13.9. Company 9 92
13.10. Company 10 92
List of Figures
FIG NO. 1. Middle East Retail Pharmacy Market Revenue, 2018 – 2032 (USD Million) 22
FIG NO. 2. Porter’s Five Forces Analysis for Middle East Retail Pharmacy Market 28
FIG NO. 3. Company Share Analysis, 2024 29
FIG NO. 4. Company Share Analysis, 2024 30
FIG NO. 5. Company Share Analysis, 2024 30
FIG NO. 6. Company Share Analysis, 2024 31
FIG NO. 7. Middle East Retail Pharmacy Market – Company Revenue Market Share, 2024 32
FIG NO. 8. Middle East Retail Pharmacy Market Revenue Share, By Type of Pharmacy, 2023 & 2032 38
FIG NO. 9. Market Attractiveness Analysis, By Type of Pharmacy 39
FIG NO. 10. Incremental Revenue Growth Opportunity by Type of Pharmacy, 2024 – 2032 39
FIG NO. 11. Middle East Retail Pharmacy Market Revenue, By Type of Pharmacy, 2018, 2023, 2027 & 2032 40
FIG NO. 12. Middle East Retail Pharmacy Market for Chain Pharmacies, Revenue (USD Million) 2018 – 2032 41
FIG NO. 13. Middle East Retail Pharmacy Market for Independent Pharmacies, Revenue (USD Million) 2018 – 2032 42
FIG NO. 14. Middle East Retail Pharmacy Market for Hospital Pharmacies, Revenue (USD Million) 2018 – 2032 43
FIG NO. 15. Middle East Retail Pharmacy Market for Mail Order Pharmacies, Revenue (USD Million) 2018 – 2032 44
FIG NO. 16. Middle East Retail Pharmacy Market for Online Pharmacies, Revenue (USD Million) 2018 – 2032 45
FIG NO. 17. Middle East Retail Pharmacy Market Revenue Share, By Type of Prescription, 2023 & 2032 47
FIG NO. 18. Market Attractiveness Analysis, By Type of Prescription 48
FIG NO. 19. Incremental Revenue Growth Opportunity by Type of Prescription, 2024 – 2032 48
FIG NO. 20. Middle East Retail Pharmacy Market Revenue, By Type of Prescription, 2018, 2023, 2027 & 2032 49
FIG NO. 21. Middle East Retail Pharmacy Market for Prescription Drugs (Rx), Revenue (USD Million) 2018 – 2032 50
FIG NO. 22. Middle East Retail Pharmacy Market for Over-the-Counter (OTC) Drugs, Revenue (USD Million) 2018 – 2032 51
FIG NO. 23. Middle East Retail Pharmacy Market Revenue Share, By Service Offered, 2023 & 2032 53
FIG NO. 24. Market Attractiveness Analysis, By Service Offered 54
FIG NO. 25. Incremental Revenue Growth Opportunity by Service Offered, 2024 – 2032 54
FIG NO. 26. Middle East Retail Pharmacy Market Revenue, By Service Offered, 2018, 2023, 2027 & 2032 55
FIG NO. 27. Middle East Retail Pharmacy Market for Medication Dispensing, Revenue (USD Million) 2018 – 2032 56
FIG NO. 28. Middle East Retail Pharmacy Market for Health Screenings, Revenue (USD Million) 2018 – 2032 57
FIG NO. 29. Middle East Retail Pharmacy Market for Vaccination Services, Revenue (USD Million) 2018 – 2032 58
FIG NO. 30. Middle East Retail Pharmacy Market for Consultation and Counseling, Revenue (USD Million) 2018 – 2032 59
FIG NO. 31. Middle East Retail Pharmacy Market for Chronic Disease Management, Revenue (USD Million) 2018 – 2032 60
FIG NO. 32. Middle East Retail Pharmacy Market Revenue Share, By Product Type, 2023 & 2032 62
FIG NO. 33. Market Attractiveness Analysis, By Product Type 63
FIG NO. 34. Incremental Revenue Growth Opportunity by Product Type, 2024 – 2032 63
FIG NO. 35. Middle East Retail Pharmacy Market Revenue, By Product Type, 2018, 2023, 2027 & 2032 64
FIG NO. 36. Middle East Retail Pharmacy Market for Generic Drugs, Revenue (USD Million) 2018 – 2032 65
FIG NO. 37. Middle East Retail Pharmacy Market for Branded Drugs, Revenue (USD Million) 2018 – 2032 66
FIG NO. 38. Middle East Retail Pharmacy Market Revenue Share, By Application , 2023 & 2032 68
FIG NO. 39. Market Attractiveness Analysis, By Application 69
FIG NO. 40. Incremental Revenue Growth Opportunity by Application , 2024 – 2032 69
FIG NO. 41. Middle East Retail Pharmacy Market Revenue, By Application , 2018, 2023, 2027 & 2032 70
FIG NO. 42. Middle East Retail Pharmacy Market for Oncology, Revenue (USD Million) 2018 – 2032 71
FIG NO. 43. Middle East Retail Pharmacy Market for Diabetes, Revenue (USD Million) 2018 – 2032 72
FIG NO. 44. Middle East Retail Pharmacy Market for Neurology, Revenue (USD Million) 2018 – 2032 73
FIG NO. 45. Middle East Retail Pharmacy Market for Others, Revenue (USD Million) 2018 – 2032 74
FIG NO. 46. Middle East Retail Pharmacy Market Revenue Share, By Customer Segment, 2023 & 2032 76
FIG NO. 47. Market Attractiveness Analysis, By Customer Segment 77
FIG NO. 48. Incremental Revenue Growth Opportunity by Customer Segment, 2024 – 2032 77
FIG NO. 49. Middle East Retail Pharmacy Market Revenue, By Customer Segment, 2018, 2023, 2027 & 2032 78
FIG NO. 50. Middle East Retail Pharmacy Market for Pediatric, Revenue (USD Million) 2018 – 2032 79
FIG NO. 51. Middle East Retail Pharmacy Market for Adults, Revenue (USD Million) 2018 – 2032 80
FIG NO. 52. Middle East Retail Pharmacy Market for Geriatric, Revenue (USD Million) 2018 – 2032 80
FIG NO. 53. Middle East Retail Pharmacy Market Revenue, 2018 – 2032 (USD Million) 81
List of Tables
TABLE NO. 1. : Middle East Retail Pharmacy Market: Snapshot 21
TABLE NO. 2. : Drivers for the Middle East Retail Pharmacy Market: Impact Analysis 24
TABLE NO. 3. : Restraints for the Middle East Retail Pharmacy Market: Impact Analysis 26
TABLE NO. 4. : Middle East Retail Pharmacy Market Revenue, By Country, 2018 – 2023 (USD Million) 82
TABLE NO. 5. : Middle East Retail Pharmacy Market Revenue, By Country, 2024 – 2032 (USD Million) 82
TABLE NO. 6. : Middle East Retail Pharmacy Market Revenue, By Type of Pharmacy, 2018 – 2023 (USD Million) 83
TABLE NO. 7. : Middle East Retail Pharmacy Market Revenue, By Type of Pharmacy, 2024 – 2032 (USD Million) 83
TABLE NO. 8. : Middle East Retail Pharmacy Market Revenue, By Type of Prescription, 2018 – 2023 (USD Million) 84
TABLE NO. 9. : Middle East Retail Pharmacy Market Revenue, By Type of Prescription, 2024 – 2032 (USD Million) 84
TABLE NO. 10. : Middle East Retail Pharmacy Market Revenue, By Service Offered, 2018 – 2023 (USD Million) 85
TABLE NO. 11. : Middle East Retail Pharmacy Market Revenue, By Service Offered, 2024 – 2032 (USD Million) 85
TABLE NO. 12. : Middle East Retail Pharmacy Market Revenue, By Product Type, 2018 – 2023 (USD Million) 86
TABLE NO. 13. : Middle East Retail Pharmacy Market Revenue, By Product Type, 2024 – 2032 (USD Million) 86
TABLE NO. 14. : Middle East Retail Pharmacy Market Revenue, By Application, 2018 – 2023 (USD Million) 87
TABLE NO. 15. : Middle East Retail Pharmacy Market Revenue, By Application, 2024 – 2032 (USD Million) 87
TABLE NO. 16. : Middle East Retail Pharmacy Market Revenue, By Customer Segment, 2018 – 2023 (USD Million) 88
TABLE NO. 17. : Middle East Retail Pharmacy Market Revenue, By Customer Segment, 2024 – 2032 (USD Million) 88
Frequently Asked Questions:
What is the projected market size of the Middle East retail pharmacy market in 2024 and 2032?
The Middle East retail pharmacy market is projected to grow from USD 44,172.86 million in 2024 to USD 52,982.57 million by 2032. This growth reflects expanding healthcare services and rising pharmaceutical demands in the region.
What is the compound annual growth rate (CAGR) of the Middle East retail pharmacy market?
The Middle East retail pharmacy market is expected to grow at a compound annual growth rate (CAGR) of 2.30% from 2025 to 2032. This steady growth is driven by advancements in healthcare infrastructure and evolving consumer needs.
What are the key drivers of growth in the Middle East retail pharmacy market?
The market is driven by increasing healthcare expenditures, an aging population, and the growing prevalence of chronic diseases. The rise of over-the-counter (OTC) medications and e-pharmacy services also contribute significantly to market expansion.
Which countries are leading the retail pharmacy market in the Middle East?
Saudi Arabia and the UAE are the leading countries in the Middle East retail pharmacy market. Their robust healthcare policies and significant investments in medical infrastructure fuel the demand for pharmaceutical services.
Who are the key players in the Middle East retail pharmacy market?
Key players in the market include Nahdi Medical Company, Al-Dawaa Medical Services Co., and BinSina Pharmacy. These companies are expanding their presence both through physical stores and digital platforms to cater to the region’s evolving healthcare needs.
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$3699
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$4699
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.
